Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum

European Journal of Pharmacology

Volumn 303, Issue 3, 1996, Pages 247-251

  Ishibashi, Tadashi ^a   Ikeda, Kazuhito ^a   Ishida, Kumiko ^a   Yasui, Junko ^a   Tojima, Rie ^a   Nakamura, Mitsutaka ^a   Ohno, Yukihiro ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

5 HT2 receptor; antipsychotic; c fos mRNA; haloperidol; SM 9018; striatum

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; OXIDOPAMINE; PEROSPIRONE; PROTEIN C FOS; RITANSERIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG ANTAGONISM; GENE EXPRESSION; IMMEDIATE EARLY GENE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029995536     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00139-2     Document Type: Article

References (18)

1. Chomczynski, P. and N. Sacchi, 1987, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156.
2. Dewey, S.L., G.S. Smith, J. Logan, D. Alexoff, Y.-S. Ding, P. King, N. Pappas, J.D. Brodie and C.R. Ashby, Jr., 1995, Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis, J. Neurosci. 15, 821.
3. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons, Neuroscience 37, 287.
4. Fink-Jensen, A. and P. Kristensen, 1994, Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain, Neurosci. Lett. 182, 115.
5. Guo, N., G.S. Robertson and H.C. Fibiger, 1992, Scopolamine attenuates haloperidol-induced c-fos expression in the striatum, Brain Res. 588, 164.
6. 2 antagonistic actions, Jpn. J. Pharmacol. 53, 321.
7. 3H]acetylcholine release from rat striatal slices, Gen. Pharmacol., in press.
8. Kato, T., A. Hirose, Y. Ohno, H. Shimizu, H. Tanaka and M. Nakamura, 1990, Binding profile of SM-9018, a novel antipsychotic candidate, Jpn. J. Pharmacol. 54, 478.
9. Meltzer, H.Y. and J.F. Nash, 1991, Effects of antipsychotic drugs on serotonin receptors, Pharmacol. Rev. 43, 587.
10. Miller, J.C., 1990, Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs, J. Neurochem. 54, 1453.
11. Morgan, J.I. and T. Curran, 1989, Stimulus-transcription coupling in neuron: role of cellular immediate-early genes, Trends Neurosci. 12, 459.
12. Nguyen, T.V., B.E. Kosofsky, R. Birnbaum, B.M. Cohen and S.E. Hyman, 1992, Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine, Proc. Natl. Acad. Sci. USA 89, 4270.
13. 2 receptor antagonist, using the mouse pole test, Pharmacol. Biochem. Behav. 49, 19.
14. 2 antagonist, on dopamine and 5-HT receptors in rats, Prog. Neuro-Psychopharmacol. Biol. Psychiat. 19, 1091.
15. Robertson, G.S. and H.C. Fibiger, 1992, Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine, Neuroscience 46, 315.
16. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons, Neuroscience 49, 285.
17. Robertson, G.S., H. Matsumura and H.C. Fibiger, 1994, Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity, J. Pharmacol. Exp. Ther. 271, 1058.
18. 2 antagonists modulates the effects of D-2 dopamine receptor blockade, J. Pharmacol. Exp. Ther. 253, 1162.